Reprozin CR Sustained Release Tablets (Levodropropizine)

Adult dose

Adults: Take 1 tablet per dose (equivalent to 90mg of levodropropizine) orally 2 times daily. This medicine is an extended-release formulation; swallow it whole without splitting or crushing it.

This drug should not be used by patients who are allergic to this drug or its components. It should not be administered to patients with excessive bronchial mucus secretion. Patients with ciliary dysfunction disorders, such as Kartagener syndrome or ciliary dyskinesia, should not use this medication. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. This drug should be avoided in patients with severely impaired liver function. Since this medication contains lactose, patients with lactose intolerance or genetic carbohydrate absorption disorders should not take it. Patients with severe heart failure or significantly reduced kidney function should use this medication with caution. Elderly patients and children require special attention, and for children, it is preferable to use an alternative formulation that can be divided rather than this sustained-release preparation. During treatment with this medication, drowsiness or dizziness may occur, so caution should be exercised when driving or operating machinery, especially when taken with alcohol, as these symptoms may be intensified. When taken with sedatives, drug interactions may occur, so caution is advised. Store this medication in a safe place out of reach of children and do not transfer it to another container, as this is better for maintaining the quality.

• Area
• indigestion
• constipation
• drowsiness
• headache
• dizziness
• positional vertigo
• eyelid edema
• increased leukocytes in urine
• elevated ALT

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is advisable to store the medication at room temperature between 1°C and 30°C, avoiding extremely hot or cold places.

Appearance

A rectangular sustained release tablet consisting of a white to light yellow upper part and a white lower part.

Package unit

Inner use - 30 tablets/bottle, Inner use - 300 tablets/bottle